Publication | Closed Access

Naringenin ameliorates Alzheimer’s disease (AD)-type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular-streptozotocin in rat model

Neurodegenerative DiseasesAlzheimer's DiseaseMedicineNeuropharmacologyDegenerative PathologyNeuroprotectionNeuroscienceNeurologyNeurodegenerationPharmacologyNeurochemistryRat Model